Published in Biochem J on October 01, 2004
Functions of cell surface-anchored antigen I/II family and Hsa polypeptides in interactions of Streptococcus gordonii with host receptors. Infect Immun (2005) 1.54
Multiple components contribute to ability of saliva to inhibit influenza viruses. Oral Microbiol Immunol (2009) 1.13
Innate immunity glycoprotein gp-340 variants may modulate human susceptibility to dental caries. BMC Infect Dis (2007) 1.02
Deleted in malignant brain tumors-1 protein (DMBT1): a pattern recognition receptor with multiple binding sites. Int J Mol Sci (2010) 0.92
Streptococcus pyogenes antigen I/II-family polypeptide AspA shows differential ligand-binding properties and mediates biofilm formation. Mol Microbiol (2011) 0.92
Respiratory Deleted in Malignant Brain Tumours 1 (DMBT1) levels increase during lung maturation and infection. Clin Exp Immunol (2007) 0.88
Variant size- and glycoforms of the scavenger receptor cysteine-rich protein gp-340 with differential bacterial aggregation. Glycoconj J (2007) 0.87
Effects of Muclin (Dmbt1) deficiency on the gastrointestinal system. Am J Physiol Gastrointest Liver Physiol (2008) 0.85
Deleted in Malignant Brain Tumors 1 (DMBT1) is present in hyaline membranes and modulates surface tension of surfactant. Respir Res (2007) 0.81
Transient and Prolonged Response of Chicken Cecum Mucosa to Colonization with Different Gut Microbiota. PLoS One (2016) 0.75
SALSA: A Regulator of the Early Steps of Complement Activation on Mucosal Surfaces. Front Immunol (2016) 0.75
Identification of the haemoglobin scavenger receptor. Nature (2001) 7.05
Collectins: collagenous C-type lectins of the innate immune defense system. Immunol Today (1994) 2.81
DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet (1997) 2.18
The SRCR superfamily: a family reminiscent of the Ig superfamily. Trends Biochem Sci (1994) 1.93
Characterization of a salivary agglutinin reacting with a serotype c strain of Streptococcus mutans. Eur J Biochem (1983) 1.92
Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J Biol Chem (2000) 1.89
Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci U S A (1999) 1.69
Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule. J Biol Chem (1997) 1.68
Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily. J Biol Chem (2002) 1.37
Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am J Physiol Lung Cell Mol Physiol (2003) 1.23
Differentiation and interaction of secretory immunoglobulin A and a calcium-dependent parotid agglutinin for several bacterial strains. Infect Immun (1987) 1.20
Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily. Nat Struct Biol (1999) 1.17
Binding of salivary glycoprotein-secretory immunoglobulin A complex to the surface protein antigen of Streptococcus mutans. Infect Immun (1998) 1.13
Adherence of mutans streptococci to other oral bacteria. Infect Immun (1990) 1.13
High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component. Mol Immunol (1993) 1.03
Human salivary agglutinin binds to lung surfactant protein-D and is identical with scavenger receptor protein gp-340. Biochem J (2001) 1.01
Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120. AIDS Res Hum Retroviruses (2003) 1.01
Identification of a nonmucin glycoprotein (gp-340) from a purified respiratory mucin preparation: evidence for an association involving the MUC5B mucin. Glycobiology (2001) 0.97
A role for Lewis a antigens on salivary agglutinin in binding to Streptococcus mutans. Antonie Van Leeuwenhoek (2000) 0.96
Immunochemical analysis of high molecular-weight human salivary mucins (MG1) using monoclonal antibodies. Arch Oral Biol (1991) 0.91
Differential distribution of salivary agglutinin and amylase in the Golgi apparatus and secretory granules of human salivary gland acinar cells. Anat Rec (1991) 0.91
Inhibitory effect of bovine milk lactoferrin on the interaction between a streptococcal surface protein antigen and human salivary agglutinin. J Biol Chem (2001) 0.90
Structure, localization and potential role of a novel molluscan trypsin inhibitor in Lymnaea. Eur J Biochem (2001) 0.89
A rapid solid-phase fluorimetric assay for measuring bacterial adherence, using DNA-binding stains. J Microbiol Methods (2003) 0.83
Interdialytic weight gain in patients on hemodialysis is associated with dry mouth and thirst. Kidney Int (2004) 1.55
Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily. J Biol Chem (2002) 1.37
α-Amylase as a reliable and convenient measure of sympathetic activity: don't start salivating just yet! Psychoneuroendocrinology (2011) 1.37
Innate secretory immunity in response to laboratory stressors that evoke distinct patterns of cardiac autonomic activity. Psychosom Med (2003) 1.27
Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains. J Biol Chem (2004) 1.26
Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization. Biochem J (2004) 1.14
Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay. FASEB J (2008) 1.13
Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with different functions in infection, inflammation and cancer. Biol Chem (2007) 1.12
Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem J (2005) 1.11
Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in Leishmania. FASEB J (2008) 1.06
Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides (2004) 1.02
Sortase A as a tool for high-yield histatin cyclization. FASEB J (2011) 1.01
Preparation of LL-37-grafted titanium surfaces with bactericidal activity. Bioconjug Chem (2006) 0.96
Stress and secretory immunity. Int Rev Neurobiol (2002) 0.95
Peptide-based fluorescence resonance energy transfer protease substrates for the detection and diagnosis of Bacillus species. Anal Chem (2011) 0.93
Reactive oxygen species play no role in the candidacidal activity of the salivary antimicrobial peptide histatin 5. Biochem J (2004) 0.93
Deleted in malignant brain tumors-1 protein (DMBT1): a pattern recognition receptor with multiple binding sites. Int J Mol Sci (2010) 0.92
Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei. Int J Antimicrob Agents (2011) 0.92
Discovery and prevalidation of salivary extracellular microRNA biomarkers panel for the noninvasive detection of benign and malignant parotid gland tumors. Clin Cancer Res (2013) 0.92
Structure-function relationship of the human antimicrobial peptide LL-37 and LL-37 fragments in the modulation of TLR responses. Biol Chem (2009) 0.92
DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligands. Eur J Immunol (2009) 0.91
The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans. Biol Chem (2006) 0.91
Improved proteolytic stability of chicken cathelicidin-2 derived peptides by D-amino acid substitutions and cyclization. Peptides (2011) 0.91
The role of salivary histatin and the human cathelicidin LL-37 in wound healing and innate immunity. Biol Chem (2010) 0.90
Neuroendocrine regulation of salivary IgA synthesis and secretion: implications for oral health. Biol Chem (2004) 0.89
Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on haemodialysis. Nephrol Dial Transplant (2005) 0.88
Implications for diagnostics in the biochemistry and physiology of saliva. Ann N Y Acad Sci (2007) 0.88
A common binding motif for various bacteria of the bacteria-binding peptide SRCRP2 of DMBT1/gp-340/salivary agglutinin. Biol Chem (2008) 0.87
Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry. J Virol (2006) 0.87
Internalisation and degradation of histatin 5 by Candida albicans. Biol Chem (2003) 0.87
The influence of oral bacteria on epithelial cell migration in vitro. Mediators Inflamm (2013) 0.87
Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides. Biochimie (2008) 0.86
Membrane interaction and antibacterial properties of two mildly cationic peptide diastereomers, bombinins H2 and H4, isolated from Bombina skin. Eur Biophys J (2011) 0.86
Osteomyelitis prevention in rabbits using antimicrobial peptide hLF1-11- or gentamicin-containing calcium phosphate cement. J Antimicrob Chemother (2004) 0.86
Highly specific protease-based approach for detection of porphyromonas gingivalis in diagnosis of periodontitis. J Clin Microbiol (2011) 0.86
Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva. Eur J Oral Sci (2002) 0.86
The effect of saliva composition on texture perception of semi-solids. Arch Oral Biol (2006) 0.86
Higher levels of salivary MUC5B and MUC7 in individuals with gastric diseases who harbor Helicobacter pylori. Arch Oral Biol (2008) 0.85
Interindividual variation, correlations, and sex-related differences in the salivary biochemistry of young healthy adults. Eur J Oral Sci (2015) 0.85
The effect of caffeine on working memory load-related brain activation in middle-aged males. Neuropharmacology (2012) 0.85
Structure-activity analysis of histatin, a potent wound healing peptide from human saliva: cyclization of histatin potentiates molar activity 1,000-fold. FASEB J (2009) 0.85
Identification of salivary components that induce transition of hyphae to yeast in Candida albicans. FEMS Yeast Res (2009) 0.83
A cathelicidin-2-derived peptide effectively impairs Staphylococcus epidermidis biofilms. Int J Antimicrob Agents (2011) 0.83
In vitro phenotypic differentiation towards commensal and pathogenic oral biofilms. Biofouling (2015) 0.83
In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile. BMC Musculoskelet Disord (2006) 0.83
Antimicrobial defense systems in saliva. Monogr Oral Sci (2014) 0.83
Sortase-mediated backbone cyclization of proteins and peptides. Biol Chem (2015) 0.83
Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli. Peptides (2005) 0.82
Detection of cytotoxin genotypes of Helicobacter pylori in stomach, saliva and dental plaque. Arch Oral Biol (2009) 0.82
Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268-284 and LFampin 265-284: Asp-Leu-Ile makes a difference. Biochem Cell Biol (2006) 0.82
Rapid detection and semi-quantification of IgG-accessible Staphylococcus aureus surface-associated antigens using a multiplex competitive Luminex assay. J Immunol Methods (2013) 0.82
A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin. Peptides (2005) 0.82
Toothbrushing affects the protein composition of whole saliva. Eur J Oral Sci (2002) 0.82
Solid-phase synthesis of a pentavalent GalNAc-containing glycopeptide (Tn antigen) representing the nephropathy-associated IgA hinge region. Carbohydr Res (2010) 0.82
A peptide domain of bovine milk lactoferrin inhibits the interaction between streptococcal surface protein antigen and a salivary agglutinin peptide domain. Infect Immun (2004) 0.82
MUC5B levels in submandibular gland saliva of patients treated with radiotherapy for head-and-neck cancer: a pilot study. Radiat Oncol (2012) 0.82
A heterodimer comprised of two bovine lactoferrin antimicrobial peptides exhibits powerful bactericidal activity against Burkholderia pseudomallei. World J Microbiol Biotechnol (2013) 0.81
Academic examinations and immunity: academic stress or examination stress? Psychosom Med (2004) 0.81
Oral and ocular manifestations in Sjögren's syndrome. J Rheumatol (2002) 0.81
Oral diseases: from detection to diagnostics. Ann N Y Acad Sci (2007) 0.80
Histatin-derived monomeric and dimeric synthetic peptides show strong bactericidal activity towards multidrug-resistant Staphylococcus aureus in vivo. Antimicrob Agents Chemother (2007) 0.80
Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome. Arch Otolaryngol Head Neck Surg (2003) 0.80
Chicken cathelicidin-2-derived peptides with enhanced immunomodulatory and antibacterial activities against biological warfare agents. Int J Antimicrob Agents (2010) 0.79
Saliva and wound healing. Chin J Dent Res (2013) 0.79
Antimicrobial activities of LL-37 and its truncated variants against Burkholderia thailandensis. Int J Antimicrob Agents (2010) 0.79
Stress as a determinant of saliva-mediated adherence and coadherence of oral and nonoral microorganisms. Psychosom Med (2003) 0.78
Patterns in consumption of potentially erosive beverages among adolescent school children in the Netherlands. Int Dent J (2011) 0.78
Evaluation of a D-amino-acid-containing fluorescence resonance energy transfer peptide library for profiling prokaryotic proteases. Anal Biochem (2013) 0.77
Prevention and treatment of salivary gland hypofunction related to head and neck radiation therapy and chemotherapy. Support Cancer Ther (2004) 0.77
Identification of the hydroxyapatite-binding domain of salivary agglutinin. Eur J Oral Sci (2013) 0.77
Effect of amino acid substitutions on the candidacidal activity of LFampin 265-284. Peptides (2005) 0.76
Sortase A as a tool to functionalize surfaces. Bioconjug Chem (2013) 0.76
The management of xerostomia in patients on haemodialysis: comparison of artificial saliva and chewing gum. Palliat Med (2005) 0.76